Skip to content

Clinical trials

Observational Peripheral Vascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Vascular Diseases Phase: Observational Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20034
20043
20051
20063
200711
20083
20093
20104
20111
20135
20143
20151
20171
20184
20194
20204
20217
20229
20234
20248
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Unknown status18
Recruiting11
Withdrawn6
Terminated5
Active, not recruiting2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
AstraZeneca4
Boston Scientific Corporation3
Abbott Medical Devices2
C. R. Bard2
Canadian Medical and Surgical Knowledge Translation Research Group2
Chengdu University of Traditional Chinese Medicine2
Hansen Medical2
Medtronic Endovascular2
Stanford University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Vascular Diseases103
Peripheral Arterial Disease31
Cardiovascular Diseases23
Coronary Disease14
Atherosclerosis13
Diabetes Mellitus13
Arterial Occlusive Diseases11
Stroke11
Heart Diseases9
Intermittent Claudication9

Trials

Showing 26 to 50 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.